DrugRepur AI: An Explainable Knowledge Graph Embedding Platform for Drug Repurposing with Multi-Level Biological Validation

Authors

  • Momin Mohammad Fuzail Maulana Azad Educational Trust’s Y. B. Chavan College of Pharmacy, Aurangabad, Maharashtra, India.
  • Barrawaz Aateka Yahya Maulana Azad Educational Trust’s Y. B. Chavan College of Pharmacy, Aurangabad, Maharashtra, India.
  • Shaikh Shoaib Iftekhar Maulana Azad Educational Trust’s Y. B. Chavan College of Pharmacy, Aurangabad, Maharashtra, India.
  • Sarfaraz Khan Maulana Azad Educational Trust’s Y. B. Chavan College of Pharmacy, Aurangabad, Maharashtra, India.

DOI:

https://doi.org/10.56511/JIPBS.2026.13108

Abstract

Background: Most computational drug repurposing systems generate predictions without providing mechanistic justification, biological context, or clinical evidence. This disconnect between prediction and understanding limits practical adoption by pharmaceutical researchers. Objective: To design and validate an integrated platform combining knowledge graph embedding-based prediction with multi-level biological validation for drug repurposing hypothesis generation. Methods: A RotatE knowledge graph embedding model was trained on a DrugBank-derived knowledge graph containing 16,698 entities and 2.94 million relational triples using PyKEEN. The prediction engine was wrapped in a validation architecture comprising dual-tiered explainability (path-based and embedding-based reasoning), disease pathway analysis, drug target identification with druggability scoring, biomarker discovery via transcriptomic reversal analysis, chemical similarity search, ClinicalTrials.gov integration, literature mining, pharmacovigilance-based safety profiling, and novelty assessment. Results: Internal validation against RepoDB yielded an MRR of 0.422, Hits@10 of 65.4%, and AUC-ROC of 0.847. External validation against the independent PREDICT dataset produced Hits@10 of 40%, confirming cross-dataset generalization. Case studies on Metformin and Hydroxychloroquine demonstrated the system across known associations, novel embedding-based predictions, and path-supported hypotheses with convergent biological evidence from pathway, transcriptomic, and chemical similarity analyses. Conclusion: Knowledge graph embeddings, when integrated within structured biological validation, can produce drug repurposing hypotheses that are scientifically defensible and clinically contextualized. The multi-level evidence architecture transforms numerical predictions into testable scientific hypotheses suitable for guiding early-stage experimental investigation.

Keywords:

Drug repurposing, knowledge graph embeddings, RotatE, explainable AI, biological validation, pharmacovigilance, pathway analysis

Downloads

Download data is not yet available.

Published

30-06-2026
Statistics
0 Views | 0 Downloads

How to Cite

Momin Mohammad Fuzail, Barrawaz Aateka Yahya, Shaikh Shoaib Iftekhar, and Sarfaraz Khan. “DrugRepur AI: An Explainable Knowledge Graph Embedding Platform for Drug Repurposing With Multi-Level Biological Validation”. Journal of Innovations in Pharmaceutical and Biological Sciences, vol. 13, no. 1, June 2026, pp. 67-75, doi:10.56511/JIPBS.2026.13108.

Issue

Section

Research Article